Literature DB >> 19387483

QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis.

J-U Appelt1, F A Giordano, M Ecker, I Roeder, N Grund, A Hotz-Wagenblatt, G Opelz, W J Zeller, H Allgayer, S Fruehauf, S Laufs.   

Abstract

Several events of insertional mutagenesis in pre-clinical and clinical gene therapy studies have created intense interest in assessing the genomic insertion profiles of gene therapy vectors. For the construction of such profiles, vector-flanking sequences detected by inverse PCR, linear amplification-mediated-PCR or ligation-mediated-PCR need to be mapped to the host cell's genome and compared to a reference set. Although remarkable progress has been achieved in mapping gene therapy vector insertion sites, public reference sets are lacking, as are the possibilities to quickly detect non-random patterns in experimental data. We developed a tool termed QuickMap, which uniformly maps and analyzes human and murine vector-flanking sequences within seconds (available at www.gtsg.org). Besides information about hits in chromosomes and fragile sites, QuickMap automatically determines insertion frequencies in +/- 250 kb adjacency to genes, cancer genes, pseudogenes, transcription factor and (post-transcriptional) miRNA binding sites, CpG islands and repetitive elements (short interspersed nuclear elements (SINE), long interspersed nuclear elements (LINE), Type II elements and LTR elements). Additionally, all experimental frequencies are compared with the data obtained from a reference set, containing 1 000 000 random integrations ('random set'). Thus, for the first time a tool allowing high-throughput profiling of gene therapy vector insertion sites is available. It provides a basis for large-scale insertion site analyses, which is now urgently needed to discover novel gene therapy vectors with 'safe' insertion profiles.

Entities:  

Mesh:

Year:  2009        PMID: 19387483     DOI: 10.1038/gt.2009.37

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  23 in total

1.  Retroviral infection of hES cells produces random-like integration patterns.

Authors:  Kwang-il Lim
Journal:  Mol Cells       Date:  2012-04-20       Impact factor: 5.034

2.  RGB marking facilitates multicolor clonal cell tracking.

Authors:  Kristoffer Weber; Michael Thomaschewski; Michael Warlich; Tassilo Volz; Kerstin Cornils; Birte Niebuhr; Maike Täger; Marc Lütgehetmann; Jörg-Matthias Pollok; Carol Stocking; Maura Dandri; Daniel Benten; Boris Fehse
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

3.  Vector integration and tumorigenesis.

Authors:  Christof von Kalle; Annette Deichmann; Manfred Schmidt
Journal:  Hum Gene Ther       Date:  2014-06       Impact factor: 5.695

4.  Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.

Authors:  Hanna Kymäläinen; J Uwe Appelt; Frank A Giordano; Angela F Davies; Caroline M Ogilvie; Sherif G Ahmed; Stephanie Laufs; Manfred Schmidt; Juergen Bode; Rafael J Yáñez-Muñoz; George Dickson
Journal:  Hum Gene Ther       Date:  2014-04-10       Impact factor: 5.695

5.  Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.

Authors:  Lucia E Rosas; Jessica L Grieves; Kimberly Zaraspe; Krista Md La Perle; Haiyan Fu; Douglas M McCarty
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

6.  Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.

Authors:  Anne Arens; Jens-Uwe Appelt; Cynthia C Bartholomae; Richard Gabriel; Anna Paruzynski; Derek Gustafson; Nathalie Cartier; Patrick Aubourg; Annette Deichmann; Hanno Glimm; Christof von Kalle; Manfred Schmidt
Journal:  Hum Gene Ther Methods       Date:  2012-05-04       Impact factor: 2.396

7.  Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.

Authors:  Julia D Suerth; Tobias Maetzig; Martijn H Brugman; Niels Heinz; Jens-Uwe Appelt; Kerstin B Kaufmann; Manfred Schmidt; Manuel Grez; Ute Modlich; Christopher Baum; Axel Schambach
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

8.  Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells.

Authors:  Cathy X Wang; Blythe D Sather; Xuefeng Wang; Jennifer Adair; Iram Khan; Swati Singh; Shanshan Lang; Amie Adams; Gabrielle Curinga; Hans-Peter Kiem; Carol H Miao; David J Rawlings; Bruce E Torbett
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

9.  VISPA: a computational pipeline for the identification and analysis of genomic vector integration sites.

Authors:  Andrea Calabria; Simone Leo; Fabrizio Benedicenti; Daniela Cesana; Giulio Spinozzi; Massimilano Orsini; Stefania Merella; Elia Stupka; Gianluigi Zanetti; Eugenio Montini
Journal:  Genome Med       Date:  2014-09-03       Impact factor: 11.117

10.  Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.

Authors:  Gaetano Romano
Journal:  ISRN Oncol       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.